161 related articles for article (PubMed ID: 12729762)
21. Crystal structure of fully ligated adenylosuccinate synthetase from Plasmodium falciparum.
Eaazhisai K; Jayalakshmi R; Gayathri P; Anand RP; Sumathy K; Balaram H; Murthy MR
J Mol Biol; 2004 Jan; 335(5):1251-64. PubMed ID: 14729341
[TBL] [Abstract][Full Text] [Related]
22. Specific inhibition of the aspartate aminotransferase of Plasmodium falciparum.
Wrenger C; Müller IB; Schifferdecker AJ; Jain R; Jordanova R; Groves MR
J Mol Biol; 2011 Jan; 405(4):956-71. PubMed ID: 21087616
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of human glutathione reductase by 10-arylisoalloxazines: crystalline, kinetic, and electrochemical studies.
Schönleben-Janas A; Kirsch P; Mittl PR; Schirmer RH; Krauth-Siegel RL
J Med Chem; 1996 Mar; 39(7):1549-54. PubMed ID: 8691487
[TBL] [Abstract][Full Text] [Related]
24. Crystal structure of Plasmodium falciparum thioredoxin reductase, a validated drug target.
Boumis G; Giardina G; Angelucci F; Bellelli A; Brunori M; Dimastrogiovanni D; Saccoccia F; Miele AE
Biochem Biophys Res Commun; 2012 Sep; 425(4):806-11. PubMed ID: 22889878
[TBL] [Abstract][Full Text] [Related]
25. Denaturation and reactivation of dimeric human glutathione reductase--an assay for folding inhibitors.
Nordhoff A; Tziatzios C; van den Broek JA; Schott MK; Kalbitzer HR; Becker K; Schubert D; Schirmer RH
Eur J Biochem; 1997 Apr; 245(2):273-82. PubMed ID: 9151953
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the glyoxalases of the malarial parasite Plasmodium falciparum and comparison with their human counterparts.
Akoachere M; Iozef R; Rahlfs S; Deponte M; Mannervik B; Creighton DJ; Schirmer H; Becker K
Biol Chem; 2005 Jan; 386(1):41-52. PubMed ID: 15843146
[TBL] [Abstract][Full Text] [Related]
27. Development of a functional assay to detect inhibitors of Plasmodium falciparum glutathione reductase utilizing liquid chromatography-mass spectrometry.
Burkard L; Scheuermann A; Simithy J; Calderón AI
Biomed Chromatogr; 2016 Apr; 30(4):543-7. PubMed ID: 26257195
[TBL] [Abstract][Full Text] [Related]
28. Glutathione mediated regulation of oligomeric structure and functional activity of Plasmodium falciparum glutathione S-transferase.
Tripathi T; Rahlfs S; Becker K; Bhakuni V
BMC Struct Biol; 2007 Oct; 7():67. PubMed ID: 17941979
[TBL] [Abstract][Full Text] [Related]
29. Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum.
Silva AM; Lee AY; Gulnik SV; Maier P; Collins J; Bhat TN; Collins PJ; Cachau RE; Luker KE; Gluzman IY; Francis SE; Oksman A; Goldberg DE; Erickson JW
Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10034-9. PubMed ID: 8816746
[TBL] [Abstract][Full Text] [Related]
30. Chloroquine binds in the cofactor binding site of Plasmodium falciparum lactate dehydrogenase.
Read JA; Wilkinson KW; Tranter R; Sessions RB; Brady RL
J Biol Chem; 1999 Apr; 274(15):10213-8. PubMed ID: 10187806
[TBL] [Abstract][Full Text] [Related]
31. Folding of the four domains and dimerization are impaired by the Gly446-->Glu exchange in human glutathione reductase. Implications for the design of antiparasitic drugs.
Nordhoff A; Bücheler US; Werner D; Schirmer RH
Biochemistry; 1993 Apr; 32(15):4060-6. PubMed ID: 8097111
[TBL] [Abstract][Full Text] [Related]
32. Glutamate dehydrogenase, the marker protein of Plasmodium falciparum--cloning, expression and characterization of the malarial enzyme.
Wagner JT; Lüdemann H; Färber PM; Lottspeich F; Krauth-Siegel RL
Eur J Biochem; 1998 Dec; 258(2):813-9. PubMed ID: 9874251
[TBL] [Abstract][Full Text] [Related]
33. Structural mapping of the ClpB ATPases of Plasmodium falciparum: Targeting protein folding and secretion for antimalarial drug design.
AhYoung AP; Koehl A; Cascio D; Egea PF
Protein Sci; 2015 Sep; 24(9):1508-20. PubMed ID: 26130467
[TBL] [Abstract][Full Text] [Related]
34. Crystal structure of the Plasmodium falciparum thioredoxin reductase-thioredoxin complex.
Fritz-Wolf K; Jortzik E; Stumpf M; Preuss J; Iozef R; Rahlfs S; Becker K
J Mol Biol; 2013 Sep; 425(18):3446-60. PubMed ID: 23845423
[TBL] [Abstract][Full Text] [Related]
35. Characterization of Plasmodium falciparum 6-Phosphogluconate Dehydrogenase as an Antimalarial Drug Target.
Haeussler K; Fritz-Wolf K; Reichmann M; Rahlfs S; Becker K
J Mol Biol; 2018 Oct; 430(21):4049-4067. PubMed ID: 30098336
[TBL] [Abstract][Full Text] [Related]
36. Antiplasmodial Activity of Nitroaromatic Compounds: Correlation with Their Reduction Potential and Inhibitory Action on
Marozienė A; Lesanavičius M; Davioud-Charvet E; Aliverti A; Grellier P; Šarlauskas J; Čėnas N
Molecules; 2019 Dec; 24(24):. PubMed ID: 31835450
[TBL] [Abstract][Full Text] [Related]
37. X-ray crystal structure and specificity of the Plasmodium falciparum malaria aminopeptidase PfM18AAP.
Sivaraman KK; Oellig CA; Huynh K; Atkinson SC; Poreba M; Perugini MA; Trenholme KR; Gardiner DL; Salvesen G; Drag M; Dalton JP; Whisstock JC; McGowan S
J Mol Biol; 2012 Sep; 422(4):495-507. PubMed ID: 22709581
[TBL] [Abstract][Full Text] [Related]
38. Recombinant Plasmodium falciparum glutathione reductase is inhibited by the antimalarial dye methylene blue.
Färber PM; Arscott LD; Williams CH; Becker K; Schirmer RH
FEBS Lett; 1998 Feb; 422(3):311-4. PubMed ID: 9498806
[TBL] [Abstract][Full Text] [Related]
39. 1,4-naphthoquinones and other NADPH-dependent glutathione reductase-catalyzed redox cyclers as antimalarial agents.
Belorgey D; Lanfranchi DA; Davioud-Charvet E
Curr Pharm Des; 2013; 19(14):2512-28. PubMed ID: 23116403
[TBL] [Abstract][Full Text] [Related]
40. Antiplasmodial activity of quinones: roles of aziridinyl substituents and the inhibition of Plasmodium falciparum glutathione reductase.
Grellier P; Maroziene A; Nivinskas H; Sarlauskas J; Aliverti A; Cenas N
Arch Biochem Biophys; 2010 Feb; 494(1):32-9. PubMed ID: 19919822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
